Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Operating Expenses: 2012-2023

Historic Operating Expenses for RedHill Biopharma (RDHL) over the last 11 years, with Jun 2023 value amounting to $4.8 million.

  • RedHill Biopharma's Operating Expenses fell 48.20% to $4.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $27.4 million, marking a year-over-year decrease of 41.47%. This contributed to the annual value of $11.7 million for FY2024, which is 44.59% down from last year.
  • As of Q2 2023, RedHill Biopharma's Operating Expenses stood at $4.8 million, which was down 30.46% from $6.9 million recorded in Q1 2023.
  • In the past 5 years, RedHill Biopharma's Operating Expenses registered a high of $20.6 million during Q2 2021, and its lowest value of $4.8 million during Q2 2023.
  • For the 3-year period, RedHill Biopharma's Operating Expenses averaged around $10.9 million, with its median value being $10.1 million (2022).
  • As far as peak fluctuations go, RedHill Biopharma's Operating Expenses surged by 122.37% in 2021, and later tumbled by 55.08% in 2022.
  • Quarterly analysis of 5 years shows RedHill Biopharma's Operating Expenses stood at $6.4 million in 2019, then skyrocketed by 112.48% to $13.6 million in 2020, then decreased by 8.43% to $12.5 million in 2021, then plummeted by 38.78% to $7.6 million in 2022, then slumped by 48.20% to $4.8 million in 2023.
  • Its Operating Expenses stands at $4.8 million for Q2 2023, versus $6.9 million for Q1 2023 and $7.6 million for Q4 2022.